Completed PHASE2 INTERVENTIONAL NCT00405496

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Inluding Iritis, Cyclitis, Iridocyclitis, and Panuveitis).

Sponsor: Sirion Therapeutics, Inc.

Conditions Anterior Uveitis

Interventions Difluprednate Ophthalmic Emulsion

Updated 4 times since 2017 Last updated: Nov 29, 2006 Started: Mar 31, 2000 Completion: Apr 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anterior Uveitis, this trial is completed. The trial is conducted by Sirion Therapeutics, Inc. and has accumulated 4 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Mar 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sirion Therapeutics, Inc.

Data source: Sirion Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.